Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Varvel NH, Bhaskar K, Patil AR, Pimplikar SW, Herrup K, Lamb BT. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. J Neurosci. 2008 Oct 22;28(43):10786-93. PubMed Abstract, View on AlzSWAN

  
Comments on Paper and Primary News
  Comment by:  Frank LaFerla, ARF Advisor
Submitted 1 November 2008  |  Permalink Posted 3 November 2008
  I recommend this paper

More evidence suggesting that AD is associated with aberrant cell cycle events (CCEs), which appears to be linked to Abeta oligomers, and blocking beta-secretase appears to diminish the CCEs.

View all comments by Frank LaFerla

  Comment by:  Jurgen Goetz, ARF Advisor
Submitted 4 November 2008  |  Permalink Posted 4 November 2008
  I recommend this paper

An excellent study supporting the mitosis failure hypothesis. We have shown previously using Affymetrix gene chips that Aβ treatment and P301L tau expression in an Alzheimer disease tissue culture model act synergistically to promote aberrant cell cycle re-entry (Hoerndli et al., 2007). Together this indicates a role for both tau and Aβ in neuronal cell cycle re-entry in AD.

View all comments by Jurgen Goetz

  Comment by:  George Perry (Disclosure)
Submitted 19 November 2008  |  Permalink Posted 21 November 2008
  I recommend this paper
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
Immunohistochemistry: rabbit anti-cyclin A2, C-terminal domain (Abcam); monoclonal mouse anti-cyclin D (ab 31450, discontinued) (Abcam) was raised and used as a marker of cell cycle antigens; monoclonal mouse anti-neuronal-specific nuclear protein/NeuN (A60) (Millipore) was used as a neuronal-specific marker.
Western Blotting: rabbit anti-APP-CT20/0443 (Calbiochem); monoclonal mouse anti-Aβ oligomers (NU1) and monoclonal mouse anti-Aβ oligomers (NU2) (gifts of W. L. Kline and M. P Lambert, Northwestern University, Evanston, IL); monoclonal mouse anti-human-Aβ (6E10) (Covance Research Products). The higher molecular weight oligomers were also recognized by oligomer-specific antibodies NU1 and NU2 (data not shown).
Immunocytochemistry of cells: monoclonal mouse anti-Map2 (HM-2) (Sigma-Aldrich) and monoclonal rat anti-BrdU (BU-1/75) (Abcam).
Protein Levels: We examined the levels of cell cycle proteins in brain sections of adult B6-R1.40 transgenic mice at a variety of ages by immunohistochemistry, coimmunostaining with the neuronal marker NeuN and cyclin A, as well as additional cell cycle proteins including cyclin D and proliferating cell nuclear antigen (data not shown). To determine whether soluble Aβ species are capable of inducing neuronal CCEs, we treated primary cortical neurons with varying concentrations of either monomeric or oligomeric preparations of Aβ as well as vehicle in the presence of BrdU for 24 h. The cultures were then fixed and coimmunostained with antibodies to Map2 and BrdU.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad